IMP
Process View
response to interferon gamma
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to interferon gamma"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.830 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.740 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.708 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.690 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.532 | ||
| IRF9 | interferon regulatory factor 9 | 0.510 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.413 | Human | |
| CCL5 | chemokine (C-C motif) ligand 5 | 0.412 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.404 | ||
| RXRA | retinoid X receptor, alpha | 0.398 | ||
| HCK | hemopoietic cell kinase | 0.385 | Human | |
| CCL2 | chemokine (C-C motif) ligand 2 | 0.384 | ||
| IL2RB | interleukin 2 receptor, beta | 0.372 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.363 | ||
| NMI | N-myc (and STAT) interactor | 0.337 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.320 | Human | |
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.308 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.304 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.227 | ||
| GBP4 | guanylate binding protein 4 | 0.217 | Mouse | |
| BIRC3 | baculoviral IAP repeat containing 3 | 0.216 | ||
| IFITM1 | interferon induced transmembrane protein 1 (9-27) | 0.209 | ||
| B2M | beta-2-microglobulin | 0.201 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.198 | ||
| IRF1 | interferon regulatory factor 1 | 0.191 | Mouse | |
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.187 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.187 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.174 | ||
| C3 | complement component 3 | 0.162 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.148 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.143 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.142 | ||
| GHR | growth hormone receptor | 0.141 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.137 | Human | |
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.135 | ||
| IDE | insulin-degrading enzyme | 0.133 | ||
| RARA | retinoic acid receptor, alpha | 0.132 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.130 | ||
| IL4R | interleukin 4 receptor | 0.129 | ||
| AIPL1 | aryl hydrocarbon receptor interacting protein-like 1 | 0.128 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.125 | Human | |
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.124 | ||
| IFIH1 | interferon induced with helicase C domain 1 | 0.117 | ||
| KLHL20 | kelch-like 20 (Drosophila) | 0.111 | ||
| PDCD6 | programmed cell death 6 | 0.110 | ||
| DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 | 0.109 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.105 | ||
| BLNK | B-cell linker | 0.103 | ||
| HLA-A | major histocompatibility complex, class I, A | 0.102 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.099 | ||
| INSR | insulin receptor | 0.099 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.094 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.094 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.092 | ||
| GBP5 | guanylate binding protein 5 | 0.091 | Mouse | |
| DPP4 | dipeptidyl-peptidase 4 | 0.091 | ||
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.088 | Mouse | |
| PPP5C | protein phosphatase 5, catalytic subunit | 0.087 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.082 | ||
| HLA-C | major histocompatibility complex, class I, C | 0.079 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.079 | Human | |
| IFI16 | interferon, gamma-inducible protein 16 | 0.078 | ||
| IL12RB2 | interleukin 12 receptor, beta 2 | 0.077 | ||
| JAK2 | Janus kinase 2 | 0.076 | Rat | |
| VCAM1 | vascular cell adhesion molecule 1 | 0.075 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.075 | Human | |
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.074 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.070 | ||
| IL1B | interleukin 1, beta | 0.069 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.069 | ||
| RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 0.069 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.066 | ||
| BTN3A1 | butyrophilin, subfamily 3, member A1 | 0.060 | ||
| CD163 | CD163 molecule | 0.059 | ||
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.058 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.056 | Human | |
| UBD | ubiquitin D | 0.056 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.056 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.054 | Human | |
| SOD2 | superoxide dismutase 2, mitochondrial | 0.054 | ||
| APOL6 | apolipoprotein L, 6 | 0.053 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.052 | ||
| HLA-G | major histocompatibility complex, class I, G | 0.051 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.050 | ||
| PHF11 | PHD finger protein 11 | 0.048 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.046 | ||
| MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 0.046 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.046 | ||
| C1S | complement component 1, s subcomponent | 0.046 | ||
| MAVS | mitochondrial antiviral signaling protein | 0.046 | ||
| EEF1G | eukaryotic translation elongation factor 1 gamma | 0.046 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.045 | ||
| OAS2 | 2'-5'-oligoadenylate synthetase 2, 69/71kDa | 0.045 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.045 | ||
| GAS7 | growth arrest-specific 7 | 0.044 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.044 | ||
| GDF9 | growth differentiation factor 9 | 0.043 | ||
| NLRC5 | NLR family, CARD domain containing 5 | 0.042 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.041 | ||
| XAF1 | XIAP associated factor 1 | 0.041 | ||
| APOL3 | apolipoprotein L, 3 | 0.041 | ||
| APOL1 | apolipoprotein L, 1 | 0.040 | ||
| C19orf66 | chromosome 19 open reading frame 66 | 0.040 | ||
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.039 | ||
| PGR | progesterone receptor | 0.039 | ||
| TLR2 | toll-like receptor 2 | 0.038 | ||
| SMN1 | survival of motor neuron 1, telomeric | 0.037 | ||
| CD83 | CD83 molecule | 0.037 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.036 | Human | |
| DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.036 | ||
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | 0.036 | ||
| IL7R | interleukin 7 receptor | 0.035 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.035 | Human | |
| TMEM140 | transmembrane protein 140 | 0.035 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.035 | ||
| CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 | 0.035 | ||
| OPTN | optineurin | 0.034 | ||
| APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.034 | ||
| PLEK | pleckstrin | 0.034 | ||
| SLC15A3 | solute carrier family 15, member 3 | 0.034 | ||
| HR | hairless homolog (mouse) | 0.034 | ||
| SLA | Src-like-adaptor | 0.034 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.034 | ||
| IL15RA | interleukin 15 receptor, alpha | 0.033 | ||
| IFNAR2 | interferon (alpha, beta and omega) receptor 2 | 0.033 | ||
| PML | promyelocytic leukemia | 0.032 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.032 | ||
| STAT4 | signal transducer and activator of transcription 4 | 0.032 | Human | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.031 | ||
| CFHR1 | complement factor H-related 1 | 0.031 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.030 | ||
| IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.030 | ||
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.030 | ||
| TYMP | thymidine phosphorylase | 0.029 | ||
| ITK | IL2-inducible T-cell kinase | 0.029 | ||
| BCL2A1 | BCL2-related protein A1 | 0.029 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.029 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.029 | Human | |
| IDO1 | indoleamine 2,3-dioxygenase 1 | 0.029 | ||
| TRIM21 | tripartite motif containing 21 | 0.028 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.028 | ||
| ASNS | asparagine synthetase (glutamine-hydrolyzing) | 0.028 | ||
| NCK1 | NCK adaptor protein 1 | 0.028 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.028 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.028 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.028 | ||
| IFI44L | interferon-induced protein 44-like | 0.027 | ||
| ZNFX1 | zinc finger, NFX1-type containing 1 | 0.027 | ||
| IFI30 | interferon, gamma-inducible protein 30 | 0.027 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.027 | ||
| ENO1 | enolase 1, (alpha) | 0.027 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.027 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.026 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.026 | ||
| MAPT | microtubule-associated protein tau | 0.026 | ||
| IFNG | interferon, gamma | 0.026 | ||
| MED25 | mediator complex subunit 25 | 0.026 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.025 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.025 | ||
| C1R | complement component 1, r subcomponent | 0.025 | ||
| IL10 | interleukin 10 | 0.025 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.025 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.024 | ||
| SP1 | Sp1 transcription factor | 0.024 | ||
| MYO6 | myosin VI | 0.024 | ||
| IFI35 | interferon-induced protein 35 | 0.024 | ||
| IL2RG | interleukin 2 receptor, gamma | 0.024 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.023 | ||
| SLAMF8 | SLAM family member 8 | 0.023 | ||
| SAMD9L | sterile alpha motif domain containing 9-like | 0.023 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.023 | ||
| PELP1 | proline, glutamate and leucine rich protein 1 | 0.023 | ||
| HNRNPK | heterogeneous nuclear ribonucleoprotein K | 0.023 | ||
| DDX21 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 | 0.023 | ||
| FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.023 | ||
| TNFAIP8 | tumor necrosis factor, alpha-induced protein 8 | 0.023 | ||
| ND1 | NADH dehydrogenase, subunit 1 (complex I) | 0.023 | ||
| MED10 | mediator complex subunit 10 | 0.023 | ||
| TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 0.023 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.023 | ||
| JAK3 | Janus kinase 3 | 0.023 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.023 | Human | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.023 | ||
| DAXX | death-domain associated protein | 0.023 | ||
| IL32 | interleukin 32 | 0.022 | ||
| PARP12 | poly (ADP-ribose) polymerase family, member 12 | 0.022 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.022 | ||
| MS4A4A | membrane-spanning 4-domains, subfamily A, member 4 | 0.022 | ||
| LGALS8 | lectin, galactoside-binding, soluble, 8 | 0.022 | ||
| OAS1 | 2',5'-oligoadenylate synthetase 1, 40/46kDa | 0.022 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.022 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.022 | Human | |
| TPT1 | tumor protein, translationally-controlled 1 | 0.022 | ||
| FPR3 | formyl peptide receptor 3 | 0.021 | ||
| IFIT3 | interferon-induced protein with tetratricopeptide repeats 3 | 0.021 | ||
| SLAMF7 | SLAM family member 7 | 0.021 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.021 | ||
| LITAF | lipopolysaccharide-induced TNF factor | 0.021 | ||
| PRMT1 | protein arginine methyltransferase 1 | 0.021 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.021 | ||
| FYB | FYN binding protein | 0.021 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.020 | Human | |
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.020 | ||
| RUNX3 | runt-related transcription factor 3 | 0.020 | ||
| MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 0.020 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.020 | ||
| CREBBP | CREB binding protein | 0.020 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.020 | ||
| SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | 0.020 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.020 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.020 | ||
| C1orf38 | chromosome 1 open reading frame 38 | 0.020 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.019 | ||
| BAZ1A | bromodomain adjacent to zinc finger domain, 1A | 0.019 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.019 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.019 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.019 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.019 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.019 | ||
| DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.018 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.018 | ||
| SECTM1 | secreted and transmembrane 1 | 0.018 | ||
| CREM | cAMP responsive element modulator | 0.018 | ||
| PGK1 | phosphoglycerate kinase 1 | 0.018 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.018 | Human | |
| PDCD6IP | programmed cell death 6 interacting protein | 0.018 | ||
| IRF8 | interferon regulatory factor 8 | 0.018 | ||
| EIF5B | eukaryotic translation initiation factor 5B | 0.018 | ||
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.018 | ||
| TAB3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | 0.017 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.017 | ||
| HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.017 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.017 | ||
| PLSCR1 | phospholipid scramblase 1 | 0.017 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.017 | ||
| TMEM173 | transmembrane protein 173 | 0.017 | ||
| STX11 | syntaxin 11 | 0.017 | ||
| LY86 | lymphocyte antigen 86 | 0.017 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.017 | ||
| BST2 | bone marrow stromal cell antigen 2 | 0.017 | ||
| AHSA1 | AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) | 0.017 | ||
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.017 | Human | |
| SELE | selectin E | 0.017 | ||
| IL4 | interleukin 4 | 0.016 | ||
| KYNU | kynureninase | 0.016 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.016 | ||
| DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.016 | ||
| C16orf53 | chromosome 16 open reading frame 53 | 0.016 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.016 | ||
| SQRDL | sulfide quinone reductase-like (yeast) | 0.016 | ||
| HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 0.015 | ||
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 0.015 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.015 | ||
| OFCC1 | orofacial cleft 1 candidate 1 | 0.015 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.015 | ||
| HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 0.015 | ||
| ADAMDEC1 | ADAM-like, decysin 1 | 0.015 | ||
| WARS | tryptophanyl-tRNA synthetase | 0.015 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.015 | ||
| DBNDD2 | dysbindin (dystrobrevin binding protein 1) domain containing 2 | 0.015 | ||
| GLTSCR2 | glioma tumor suppressor candidate region gene 2 | 0.015 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.015 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.015 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.015 | ||
| HCP5 | HLA complex P5 | 0.015 | ||
| SQSTM1 | sequestosome 1 | 0.015 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.015 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.015 | ||
| KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | 0.015 | ||
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 0.015 | ||
| PKM2 | pyruvate kinase, muscle | 0.015 | ||
| IRF4 | interferon regulatory factor 4 | 0.015 | ||
| SNX33 | sorting nexin 33 | 0.015 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.014 | Zebrafish | |
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.014 | ||
| IRF7 | interferon regulatory factor 7 | 0.014 | ||
| TRIM22 | tripartite motif containing 22 | 0.014 | ||
| ITGA1 | integrin, alpha 1 | 0.014 | ||
| IL18BP | interleukin 18 binding protein | 0.014 | ||
| HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.014 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.014 | ||
| EPSTI1 | epithelial stromal interaction 1 (breast) | 0.014 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.014 | ||
| TGS1 | trimethylguanosine synthase 1 | 0.014 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.014 | ||
| ISG20 | interferon stimulated exonuclease gene 20kDa | 0.014 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.014 | ||
| DARS | aspartyl-tRNA synthetase | 0.014 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.014 | ||
| CD247 | CD247 molecule | 0.014 | ||
| MVP | major vault protein | 0.014 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.014 | ||
| RNF213 | ring finger protein 213 | 0.014 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.014 | ||
| EGFR | epidermal growth factor receptor | 0.014 | ||
| EP300 | E1A binding protein p300 | 0.013 | ||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.013 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.013 | ||
| COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.013 | ||
| NNMT | nicotinamide N-methyltransferase | 0.013 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.013 | ||
| BECN1 | beclin 1, autophagy related | 0.013 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.013 | Human | |
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.013 | ||
| SHISA5 | shisa homolog 5 (Xenopus laevis) | 0.013 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.013 | ||
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.013 | ||
| RBMX | RNA binding motif protein, X-linked | 0.013 | ||
| ETV7 | ets variant 7 | 0.013 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.013 | ||
| SMAD9 | SMAD family member 9 | 0.013 | ||
| CH25H | cholesterol 25-hydroxylase | 0.013 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.013 | ||
| SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.013 | ||
| ALDOA | aldolase A, fructose-bisphosphate | 0.013 | ||
| PRDM1 | PR domain containing 1, with ZNF domain | 0.013 | ||
| RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.013 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.013 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.013 | ||
| CFB | complement factor B | 0.013 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.013 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.013 | ||
| IL8 | interleukin 8 | 0.013 | ||
| TAPBP | TAP binding protein (tapasin) | 0.013 | ||
| SELL | selectin L | 0.013 | ||
| MED28 | mediator complex subunit 28 | 0.013 | ||
| IL23A | interleukin 23, alpha subunit p19 | 0.013 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.013 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.013 | ||
| LY6E | lymphocyte antigen 6 complex, locus E | 0.012 | ||
| FKBP5 | FK506 binding protein 5 | 0.012 | ||
| A1BG | alpha-1-B glycoprotein | 0.012 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.012 | ||
| LDHA | lactate dehydrogenase A | 0.012 | ||
| HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.012 | ||
| IRF2 | interferon regulatory factor 2 | 0.012 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.012 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.012 | ||
| CD69 | CD69 molecule | 0.012 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.012 | ||
| UVRAG | UV radiation resistance associated gene | 0.012 | ||
| STX5 | syntaxin 5 | 0.012 | ||
| CCND3 | cyclin D3 | 0.012 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.012 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.012 | ||
| UBE2Z | ubiquitin-conjugating enzyme E2Z | 0.012 | ||
| CXCL16 | chemokine (C-X-C motif) ligand 16 | 0.012 | ||
| OASL | 2'-5'-oligoadenylate synthetase-like | 0.012 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.012 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.012 | ||
| SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.012 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.012 | ||
| CLIC2 | chloride intracellular channel 2 | 0.012 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.012 | ||
| AQP9 | aquaporin 9 | 0.012 | ||
| DARC | Duffy blood group, chemokine receptor | 0.011 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.011 | ||
| NRG1 | neuregulin 1 | 0.011 | ||
| NOS2 | nitric oxide synthase 2, inducible | 0.011 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.011 | ||
| IL12RB1 | interleukin 12 receptor, beta 1 | 0.011 | ||
| CYLD | cylindromatosis (turban tumor syndrome) | 0.011 | ||
| NINJ1 | ninjurin 1 | 0.011 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.011 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.011 | ||
| TBK1 | TANK-binding kinase 1 | 0.011 | ||
| LARS | leucyl-tRNA synthetase | 0.011 | ||
| ABI3 | ABI family, member 3 | 0.011 | ||
| FUS | fused in sarcoma | 0.011 | ||
| AIM2 | absent in melanoma 2 | 0.011 | ||
| TARDBP | TAR DNA binding protein | 0.011 | ||
| RALBP1 | ralA binding protein 1 | 0.011 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.011 | ||
| PPIA | peptidylprolyl isomerase A (cyclophilin A) | 0.011 | ||
| HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.011 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.011 | ||
| EVC2 | Ellis van Creveld syndrome 2 | 0.011 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.011 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.011 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.011 | Human | |
| PLA1A | phospholipase A1 member A | 0.011 | ||
| EMP3 | epithelial membrane protein 3 | 0.011 | ||
| CCDC117 | coiled-coil domain containing 117 | 0.011 | ||
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 0.011 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.011 | ||
| ELMO1 | engulfment and cell motility 1 | 0.011 | ||
| CTSS | cathepsin S | 0.011 | ||
| STK10 | serine/threonine kinase 10 | 0.011 | ||
| TNF | tumor necrosis factor | 0.011 | ||
| IL1A | interleukin 1, alpha | 0.011 | ||
| BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.011 | ||
| HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | 0.011 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.011 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.011 | Human | |
| IARS | isoleucyl-tRNA synthetase | 0.011 | ||
| CP | ceruloplasmin (ferroxidase) | 0.011 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.011 | ||
| STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.011 | Human | |
| S100A11 | S100 calcium binding protein A11 | 0.011 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.011 | ||
| LGALS9 | lectin, galactoside-binding, soluble, 9 | 0.011 | ||
| TEC | tec protein tyrosine kinase | 0.011 | ||
| COMMD6 | COMM domain containing 6 | 0.011 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.011 | ||
| CFI | complement factor I | 0.011 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.011 | ||
| GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.010 | ||
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.010 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.010 | ||
| C5AR1 | complement component 5a receptor 1 | 0.010 | ||
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.010 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.010 | Human | |
| HSPA8 | heat shock 70kDa protein 8 | 0.010 | ||
| SMARCD3 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 | 0.010 | ||
| AARS | alanyl-tRNA synthetase | 0.010 | ||
| CLEC2B | C-type lectin domain family 2, member B | 0.010 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.010 | ||
| TLR8 | toll-like receptor 8 | 0.010 | ||
| TRIM38 | tripartite motif containing 38 | 0.010 | ||
| APOL2 | apolipoprotein L, 2 | 0.010 | ||
| TNS3 | tensin 3 | 0.010 | ||
| RPL10 | ribosomal protein L10 | 0.010 | ||
| GNLY | granulysin | 0.010 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.010 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.010 | ||
| RHBDF2 | rhomboid 5 homolog 2 (Drosophila) | 0.010 | ||
| MED6 | mediator complex subunit 6 | 0.010 | ||
| MED13 | mediator complex subunit 13 | 0.010 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.010 | ||
| ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.010 | ||
| PPIG | peptidylprolyl isomerase G (cyclophilin G) | 0.010 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.010 | ||
| HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.010 | ||
| CD1C | CD1c molecule | 0.010 | ||
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.010 | ||
| SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.010 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.010 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.010 | ||
| CTSL1 | cathepsin L1 | 0.010 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.010 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.010 | ||
| IL13 | interleukin 13 | 0.010 | ||
| TCP10L | t-complex 10 (mouse)-like | 0.010 |